A novel computational framework revolutionizes antibody design, offering precise predictions and unlocking insights into the immune system’s structural and functional convergence. Study ...

The ADS team offers expertise and innovation in collaboration with each partner’s scientists to create customized project plans tailored to the target type, antibody design goals, and the needs ...

Compared with small molecules and conventionally selected antibodies, epitope-selective antibodies exhibit precise target selectivity that confers enhanced safety and pharmacodynamic properties.

Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Genmab (GMAB – Research Report) today and set a price target of $50.00.Invest ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This press ...